Immune tolerance considered to be a holy grail for long-term graft survival of organ transplants. However, the current methodologies, agents and strategies have failed to achieve measurable immune tolerance. Therefore, there is a need to discover alternate mediators and pathways that mediate the events leading to immune tolerance. Since aberrant proliferation is considered to be the barrier to immune tolerance, molecules that control cell cycle progression may be the key components in this process. Cyclin kinase inhibitor p21 is such a molecule, which is potent regulator of the events of cellular proliferation and apoptosis 1, 2 , the key determinants of immune tolerance. We have shown that cyclins and p21 play reciprocal role in immune activation and inflammation 3 .
] are similar to those observed with splenocytes from wild type and p21
-/-mice [ Figure 1A ], suggesting that the immunological response of p21 expressing, CD4+CD25+ and p21 deficient, CD4+CD25-cells to mitogenic stimuli is similar.
Similar to p21 deficient lymphocytes [ Figure 1B ], anti-CD3 activated CD4+CD25-T cells were not responsive to the inhibitory effects of CsA [ Figure 3B ]. This similarity can only be explained due to the inability of CsA to induce p21 expression in both p21 deficient and CD4+CD25-T cells, additionally, it also suggest an interaction between p21 and FoxP3. We performed experiments on CD4+CD25+ and CD4+CD25-T cells to understand if p21 plays any role in the function of these cells. We analyzed TGF-β and p21 mRNA in CD4+CD25+ and CD4+CD25-T cells activated with and without CsA.
The results demonstrate that CsA induced TGF-β and p21 mRNA expression in CD4+CD25+ T cells [ Figure 3C ,] but not in CD4+ CD25-T cells [ Figure 3D ]. These results suggest that TGF-β and p21 play a significant role in the function of CD4+CD25+
T cells. Therefore, these results suggest that the inability of these cells to induce expression of either TGF-β or p21, the most powerful anti-proliferative molecules may contribute to heightened proliferative response of CD4+CD25-and p21 -/-lymphocytes. we speculated that these effects of TGF-β may be via induction of p21.
Other studies also indicate similarities between cells deficient in p21 and CD4+CD25+ population, the deficiency of p21 and CD4+CD25+ cells [17] [18] [19] [20] [21] [22] [23] results in the development of spontaneous lupus-like disease. The deficiency of p21 resulted in immune activation, homeostatic proliferation and manifestation of lupus-like disease.
These findings were supported by studies [17] [18] , which demonstrated that the p21 -/-mice have increased lymphocyte activation, antibodies against dsDNA, lymphoadenopathy and glomerulonephritis similar to lupus patients. A mimic of p21 that negatively regulated T cell proliferation exhibited protective effects in a mouse model of lupus 24 . TGF-β's anti 
